Johnson & Johnson (BIT:1JNJ)

Italy flag Italy · Delayed Price · Currency is EUR
176.36
+0.40 (0.23%)
At close: Dec 3, 2025
23.04%
Market Cap 418.20B
Revenue (ttm) 78.81B
Net Income (ttm) 21.48B
Shares Out n/a
EPS (ttm) 8.85
PE Ratio 19.47
Forward PE 18.00
Dividend 4.57 (2.59%)
Ex-Dividend Date Nov 24, 2025
Volume 95
Average Volume 160
Open 176.00
Previous Close 175.96
Day's Range 176.00 - 176.46
52-Week Range 127.72 - 179.72
Beta n/a
RSI 55.45
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Borsa Italiana
Ticker Symbol 1JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.